Home / Indicator library / Biotechnology and Medical Care / Crystalvue (6527) overview
Crystalvue (6527) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Crystalvue, on one pageCrystalvue (6527) snapshot, key figures
Crystalvue (6527): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→6527: common questions
What is 6527's P/E ratio?
6527 traded at a price-to-earnings ratio of 12.30x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 6527's dividend yield?
6527's cash dividend yield was 4.17% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 6527's revenue growing?
6527 reported -17.4% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 6527's price / earnings high or low right now?
6527's price / earnings is 12.30x, which is below its one-year median of 13.89x and sits at the 14th percentile of the 11.52–16.68x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 6527's dividend yield high or low right now?
6527's dividend yield is 4.17%, which is above its one-year median of 2.96% and sits at the 93rd percentile of the 2.53–4.36% range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.